GAMMA Investing’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.9K Hold
67
﹤0.01% 3356
2026
Q1
$2.56K Buy
67
+60
+857% +$1.9K ﹤0.01% 3582
2025
Q4
$153 Sell
7
-2
-22% -$42 ﹤0.01% 4027
2025
Q3
$193 Buy
+9
New +$202 ﹤0.01% 3804
2025
Q2
Sell
-72
Closed -$2.63K 3781
2025
Q1
$2.63K Buy
72
+70
+3,500% +$2.41K ﹤0.01% 3326
2024
Q4
$61 Sell
2
-2
-50% -$66 ﹤0.01% 3758
2024
Q3
$151 Buy
+4
New +$154 ﹤0.01% 3535
2024
Q2
Sell
-3
Closed -$101 3451
2024
Q1
$101 Hold
3
﹤0.01% 3283
2023
Q4
$89 Buy
+3
New +$97 ﹤0.01% 3144

Other funds holding ATEX

GAMMA Investing's ATEX Position: Q2 2026 in Review

GAMMA Investing held its Anterix (ATEX) position steady in Q2 2026 at 67 shares worth $6.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3356.

GAMMA Investing first reported a position in ATEX in Q4 2023 and has held it in 9 quarters since. 13 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

  • GAMMA Investing held 67 shares of Anterix worth $6.9K as of Q2 2026.
  • GAMMA Investing left its Anterix share count unchanged in Q2 2026.
  • Anterix made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3356 holding.
  • GAMMA Investing first reported a position in Anterix in Q4 2023 and has held it in 9 quarters since.
  • 13 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.